From
StayCurrentMD
Risk Factors and Treatment Strategies for Anastomotic Ulcers in Pediatric Intestinal Failure
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Dec 2024 · 1 min read
In brief
In brief
This study examines anastomotic ulcers as a complication in pediatric intestinal failure patients, analyzing a large cohort to identify clinical risk factors and effective treatment approaches. The research addresses a gap in knowledge about this rare but significant source of morbidity in children with IF.
- Anastomotic ulcers are a rare but significant complication in pediatric intestinal failure patients.
- Large cohort studies are needed to identify risk factors for anastomotic ulcers beyond small case reports.
- Understanding AU risk factors can guide preventive strategies in high-risk IF patients.
- Treatment approaches for anastomotic ulcers in IF require evidence-based protocols tailored to pediatric populations.
Written by the GCMD Library team from the article.
Anastomotic ulcers (AUs) are a rare cause of morbidity in intestinal failure (IF). Prior studies of AUs have been small, descriptive reports. We evaluated a large cohort of IF patients to identify risk factors and describe treatment strategies for AUs.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
The disproportionate burden of severe obesity in youth with special needs and the role of metabolic and bariatric surgery
Published Jun 2026
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Article
Type of pledget and suture technique relative to esophageal tensile strength in long-gap esophageal atresia
Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026